Trials / Completed
CompletedNCT03427983
Hydrodissection as a Treatment for Carpal Tunnel Syndrome
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 21 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This is a pilot study designed to acquire data on the added value of hydrodissection when using a corticosteroid injection as a treatment for patients with carpal tunnel syndrome. Hydrodissection is part of a standard clinical care injection under ultrasound guidance in which the fluid is used to separate the nerve from surrounding structures.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Hydrodissection | Additional 3cc's of saline is used to establish an increase in hydrodissection during routine treatment. |
| PROCEDURE | Regular Injection | Corticosteroid and lidocaine injection without additional saline is used as routine treatment. |
Timeline
- Start date
- 2018-03-08
- Primary completion
- 2019-07-31
- Completion
- 2019-07-31
- First posted
- 2018-02-09
- Last updated
- 2019-08-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03427983. Inclusion in this directory is not an endorsement.